Dyne Therapeutics
200 hedge funds and large institutions have $2.63B invested in Dyne Therapeutics in 2024 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 68 increasing their positions, 63 reducing their positions, and 34 closing their positions.
12% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 34
8% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 63
0% more funds holding
Funds holding: 200 → 200 (0)
2.29% less ownership
Funds ownership: 111.98% → 109.69% (-2.3%)
30% less funds holding in top 10
Funds holding in top 10: 10 → 7 (-3)
35% less capital invested
Capital invested by funds: $4.03B → $2.63B (-$1.4B)
65% less call options, than puts
Call options by funds: $3.57M | Put options by funds: $10.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
+$53.2M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$24.3M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
+$20.1M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$16.7M |
| 5 |
O
OrbiMed
New York
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$47.3M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$37.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$30.5M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$24.8M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$23.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSG
226
Summit Securities Group
New York
| – | -$36K | -1,000 | Closed |
|
|
QT
227
Quantbot Technologies
New York
| – | -$34.4K | -959 | Closed |
|
|
ACM
228
ADAR1 Capital Management
Austin,
Texas
| – | -$14.4K | -400 | Closed |
|
|
TWD
229
True Wealth Design
Akron,
Ohio
| – | -$3.52K | -98 | Closed |
|
|
CPA
230
Capital Performance Advisors
Walnut Creek,
California
| – | -$2.91K | -81 | Closed |
|
231
Bessemer Group
Woodbridge,
New Jersey
| – | -$2K | -60 | Closed |
|
|
CFO
232
CVA Family Office
Denver,
Colorado
| – | -$431 | -12 | Closed |
|
|
AF
233
Allworth Financial
Folsom,
California
| – | -$180 | -5 | Closed |
|
234
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$36 | -1 | Closed |
|
DYN Hedge Fund Activity: Q4 2024 in Review
200 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Dyne Therapeutics (DYN) for Q4 2024, worth a combined $2.63B — down 35% from $4.03B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new DYN positions and 34 closed out — a net gain of 4 holders — while 68 added to existing stakes and 63 trimmed.
The largest buyer was Jefferies Financial Group, opening a new position worth an estimated $53.2M. The largest seller was RTW Investments, cutting an estimated $47.3M.
- 200 institutional investors held Dyne Therapeutics (DYN) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $2.63B of Dyne Therapeutics stock for Q4 2024, down 35% quarter-over-quarter.
- 38 funds opened new Dyne Therapeutics positions in Q4 2024 and 34 closed out, a net change of +4 holders.
- The largest Dyne Therapeutics buyer in Q4 2024 was Jefferies Financial Group, an estimated $53.2M added.
- The largest Dyne Therapeutics seller in Q4 2024 was RTW Investments, an estimated $47.3M sold.
Based on aggregated 13F filings for Q4 2024.